| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.94 | 0.003 | 0.94 | Aldehyde oxidase inhibitor | 0.381 0.05 CID_154700107 | ||
| 0.869 | 0.004 | 0.869 | Caspase 9 stimulant | 0.862 0.005 CID_154700107 | ||
| 0.788 | 0.004 | 0.883 | Histamine release inhibitor | 0.883 0.003 CID_154700107 | CID_154700107 | |
| 0.776 | 0.002 | 0.776 | GABA C receptor rho-3 antagonist | 0.333 0.095 CID_154700107 | ||
| 0.772 | 0.002 | 0.772 | Peroxidase inhibitor | 0.283 0.041 CID_154700107 | ||
| 0.742 | 0.005 | 0.797 | Free radical scavenger | 0.797 0.004 CID_154700107 | CID_154700107 | |
| 0.725 | 0.002 | 0.725 | Cystathionine beta-synthase inhibitor | 0.674 0.002 CID_154700107 | ||
| 0.722 | 0.005 | 0.839 | Antioxidant | 0.839 0.004 CID_154700107 | CID_154700107 | |
| 0.732 | 0.025 | 0.782 | Apoptosis agonist | 0.782 0.019 CID_154700107 | CID_154700107 | |
| 0.683 | 0.008 | 0.683 | 12-Lipoxygenase inhibitor | |||
| 0.675 | 0.005 | 0.736 | 5 Hydroxytryptamine release inhibitor | 0.736 0.004 CID_154700107 | CID_154700107 | |
| 0.666 | 0.005 | 0.666 | Amyloid beta aggregation inhibitor | 0.441 0.02 CID_154700107 | ||
| 0.67 | 0.015 | 0.67 | 15-Lipoxygenase inhibitor | |||
| 0.661 | 0.011 | 0.661 | Aryl hydrocarbon receptor agonist | 0.242 0.082 CID_154700107 | ||
| 0.626 | 0.003 | 0.626 | Aldehyde dehydrogenase inhibitor | 0.586 0.004 CID_154700107 | ||
| 0.597 | 0.001 | 0.597 | Creatine kinase inhibitor | 0.213 0.009 CID_154700107 | ||
| 0.597 | 0.01 | 0.597 | Caspase 3 stimulant | 0.513 0.019 CID_154700107 | ||
| 0.589 | 0.007 | 0.589 | Superoxide dismutase inhibitor | |||
| 0.563 | 0.01 | 0.563 | Calcium channel L-type activator | 0.349 0.118 CID_154700107 | ||
| 0.583 | 0.033 | 0.854 | Transcription factor NF kappa B inhibitor | 0.854 0.01 CID_154700107 | CID_154700107 | |
| 0.554 | 0.004 | 0.554 | Breast cancer-resistant protein inhibitor | 0.084 0.074 CID_154700107 | ||
| 0.535 | 0.006 | 0.535 | MAO inhibitor | |||
| 0.53 | 0.005 | 0.53 | MAO A inhibitor | |||
| 0.529 | 0.007 | 0.814 | Monophenol monooxygenase inhibitor | 0.814 0.003 CID_154700107 | CID_154700107 | |
| 0.522 | 0.003 | 0.522 | GABA C receptor rho-2 antagonist | 0.148 0.077 CID_154700107 | ||
| 0.523 | 0.006 | 0.745 | Melanin inhibitor | 0.745 0.003 CID_154700107 | CID_154700107 | |
| 0.53 | 0.015 | 0.53 | Lipoxygenase inhibitor | |||
| 0.572 | 0.06 | 0.818 | Alpha-glucosidase inhibitor | 0.818 0.016 CID_154700107 | CID_154700107 | |
| 0.515 | 0.013 | 0.578 | Hypoxia-inducible factor 1 alpha inhibitor | 0.578 0.009 CID_154700107 | CID_154700107 | |
| 0.501 | 0.004 | 0.501 | Interleukin 4 antagonist | 0.31 0.008 CID_154700107 | ||
| 0.499 | 0.004 | 0.499 | Estrogen receptor beta antagonist | 0.103 0.06 CID_154700107 | ||
| 0.492 | 0.004 | 0.492 | NADPH oxidase inhibitor | 0.414 0.005 CID_154700107 | ||
| 0.485 | 0.004 | 0.485 | Estrogen antagonist | 0.141 0.027 CID_154700107 | ||
| 0.506 | 0.026 | 0.506 | 5 Hydroxytryptamine release stimulant | 0.334 0.06 CID_154700107 | ||
| 0.479 | 0.006 | 0.778 | Amylase inhibitor | 0.778 0.002 CID_154700107 | CID_154700107 | |
| 0.482 | 0.01 | 0.482 | Pyruvate kinase inhibitor | 0.179 0.094 CID_154700107 | ||
| 0.475 | 0.007 | 0.497 | Topoisomerase II inhibitor | 0.497 0.007 CID_154700107 | CID_154700107 | |
| 0.538 | 0.073 | 0.834 | Antiinflammatory | 0.834 0.011 CID_154700107 | CID_154700107 | |
| 0.469 | 0.004 | 0.679 | Xanthine oxidase inhibitor | 0.679 0.003 CID_154700107 | CID_154700107 | |
| 0.463 | 0.003 | 0.463 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.139 0.022 CID_154700107 | ||
| 0.461 | 0.011 | 0.461 | P-glycoprotein inhibitor | 0.32 0.025 CID_154700107 | ||
| 0.469 | 0.02 | 0.685 | Vasodilator, coronary | 0.685 0.005 CID_154700107 | CID_154700107 | |
| 0.454 | 0.007 | 0.454 | 5 Hydroxytryptamine uptake stimulant | 0.208 0.137 CID_154700107 | ||
| 0.439 | 0.005 | 0.439 | Acetylcholinesterase inhibitor | 0.13 0.069 CID_154700107 | ||
| 0.436 | 0.007 | 0.506 | NOS3 expression enhancer | 0.506 0.005 CID_154700107 | CID_154700107 | |
| 0.438 | 0.011 | 0.438 | Dual specificity phosphatase inhibitor | |||
| 0.433 | 0.006 | 0.433 | MAO B inhibitor | |||
| 0.44 | 0.014 | 0.44 | RNA-directed DNA polymerase inhibitor | 0.384 0.02 CID_154700107 | ||
| 0.432 | 0.006 | 0.432 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.363 0.011 CID_154700107 | ||
| 0.445 | 0.022 | 0.568 | Antiamyloidogenic | 0.568 0.01 CID_154700107 | CID_154700107 | |
| 0.453 | 0.03 | 0.58 | Spasmolytic | 0.58 0.015 CID_154700107 | CID_154700107 | |
| 0.444 | 0.021 | 0.751 | Hypoglycemic | 0.751 0.004 CID_154700107 | CID_154700107 | |
| 0.448 | 0.028 | 0.607 | Apoptosis antagonist | 0.607 0.009 CID_154700107 | CID_154700107 | |
| 0.416 | 0.004 | 0.416 | Carbonic anhydrase III inhibitor | 0.264 0.008 CID_154700107 | ||
| 0.418 | 0.006 | 0.418 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.432 | 0.022 | 0.605 | Nitric oxide antagonist | 0.605 0.009 CID_154700107 | CID_154700107 | |
| 0.461 | 0.051 | 0.461 | Prostaglandin dehydrogenase inhibitor | |||
| 0.408 | 0.005 | 0.408 | Topoisomerase II alpha inhibitor | 0.383 0.005 CID_154700107 | ||
| 0.418 | 0.025 | 0.454 | DNA damaging | 0.454 0.019 CID_154700107 | CID_154700107 | |
| 0.441 | 0.06 | 0.707 | Antibacterial | 0.707 0.008 CID_154700107 | CID_154700107 | |
| 0.394 | 0.02 | 0.394 | Transcription factor STAT inhibitor | 0.196 0.144 CID_154700107 | ||
| 0.379 | 0.006 | 0.379 | Chelator | 0.146 0.037 CID_154700107 | ||
| 0.387 | 0.015 | 0.387 | Dual specificity phosphatase 3 inhibitor | |||
| 0.369 | 0.004 | 0.369 | Estrogen receptor alpha antagonist | |||
| 0.389 | 0.025 | 0.483 | Vasodilator | 0.483 0.013 CID_154700107 | CID_154700107 | |
| 0.374 | 0.011 | 0.466 | Lipid peroxidase inhibitor | 0.466 0.006 CID_154700107 | CID_154700107 | |
| 0.368 | 0.004 | 0.779 | Beta glucuronidase inhibitor | 0.779 0.002 CID_154700107 | CID_154700107 | |
| 0.367 | 0.004 | 0.367 | Carbonic anhydrase VI inhibitor | 0.195 0.014 CID_154700107 | ||
| 0.362 | 0.004 | 0.362 | Histidine decarboxylase inhibitor | |||
| 0.357 | 0.013 | 0.357 | Cholinergic | |||
| 0.347 | 0.005 | 0.347 | Carbonic anhydrase XV inhibitor | |||
| 0.345 | 0.007 | 0.345 | 5-Lipoxygenase inhibitor | |||
| 0.346 | 0.008 | 0.346 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.341 | 0.004 | 0.341 | GABA C receptor antagonist | |||
| 0.342 | 0.005 | 0.344 | Nitric-oxide synthase stimulant | 0.344 0.005 CID_154700107 | CID_154700107 | |
| 0.341 | 0.006 | 0.341 | Succinate dehydrogenase inhibitor | 0.186 0.061 CID_154700107 | ||
| 0.352 | 0.019 | 0.616 | Hepatoprotectant | 0.616 0.004 CID_154700107 | CID_154700107 | |
| 0.337 | 0.005 | 0.337 | Estrogen agonist | 0.151 0.011 CID_154700107 | ||
| 0.362 | 0.03 | 0.362 | Insulysin inhibitor | |||
| 0.345 | 0.021 | 0.512 | Platelet adhesion inhibitor | 0.512 0.005 CID_154700107 | CID_154700107 | |
| 0.323 | 0.003 | 0.323 | GABA C receptor rho-1 antagonist | 0.089 0.079 CID_154700107 | ||
| 0.325 | 0.012 | 0.346 | Neurotrophic factor enhancer | 0.346 0.009 CID_154700107 | CID_154700107 | |
| 0.36 | 0.048 | 0.36 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.315 | 0.004 | 0.315 | Multidrug resistance-associated protein 1 inhibitor | 0.249 0.005 CID_154700107 | ||
| 0.32 | 0.01 | 0.345 | Alkaline phosphatase inhibitor | 0.345 0.008 CID_154700107 | CID_154700107 | |
| 0.325 | 0.017 | 0.325 | Tubulin antagonist | |||
| 0.321 | 0.016 | 0.321 | Protein-tyrosine phosphatase inhibitor | 0.266 0.027 CID_154700107 | ||
| 0.34 | 0.036 | 0.34 | Transcription factor STAT3 inhibitor | 0.195 0.141 CID_154700107 | ||
| 0.33 | 0.026 | 0.33 | MAP kinase kinase 2 inhibitor | |||
| 0.36 | 0.059 | 0.36 | Streptokinase A inhibitor | |||
| 0.346 | 0.053 | 0.346 | Calcium channel activator | |||
| 0.327 | 0.04 | 0.827 | Angiogenesis stimulant | 0.827 0.003 CID_154700107 | CID_154700107 | |
| 0.296 | 0.01 | 0.296 | Butyrylcholinesterase inhibitor | |||
| 0.289 | 0.005 | 0.289 | Aldose reductase inhibitor | 0.238 0.005 CID_154700107 | ||
| 0.301 | 0.017 | 0.48 | Protein kinase stimulant | 0.48 0.005 CID_154700107 | CID_154700107 | |
| 0.326 | 0.042 | 0.326 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.301 | 0.02 | 0.481 | Interferon gamma antagonist | 0.481 0.007 CID_154700107 | CID_154700107 | |
| 0.283 | 0.005 | 0.283 | Alcohol oxidase inhibitor | |||
| 0.281 | 0.007 | 0.3 | Carbonic anhydrase XIII inhibitor | 0.3 0.006 CID_154700107 | CID_154700107 | |
| 0.287 | 0.019 | 0.287 | Bone formation stimulant | 0.184 0.04 CID_154700107 | ||
| 0.283 | 0.017 | 0.283 | Heat shock protein 90 alpha antagonist | |||
| 0.265 | 0.003 | 0.265 | DOPA decarboxylase inhibitor | 0.111 0.057 CID_154700107 | ||
| 0.265 | 0.006 | 0.265 | Uric acid excretion stimulant | 0.262 0.006 CID_154700107 | ||
| 0.267 | 0.009 | 0.652 | Mediator release inhibitor | 0.652 0.003 CID_154700107 | CID_154700107 | |
| 0.262 | 0.005 | 0.262 | Macrophage migration inhibitory factor inhibitor | |||
| 0.287 | 0.031 | 0.559 | Non-steroidal antiinflammatory agent | 0.559 0.005 CID_154700107 | CID_154700107 | |
| 0.271 | 0.015 | 0.271 | Heat shock protein 90 antagonist | |||
| 0.268 | 0.014 | 0.349 | Topoisomerase I inhibitor | 0.349 0.008 CID_154700107 | CID_154700107 | |
| 0.262 | 0.008 | 0.262 | Telomerase inhibitor | 0.07 0.052 CID_154700107 | ||
| 0.296 | 0.043 | 0.446 | Cyclic AMP phosphodiesterase inhibitor | 0.446 0.011 CID_154700107 | CID_154700107 | |
| 0.256 | 0.005 | 0.256 | CF transmembrane conductance regulator agonist | 0.199 0.022 CID_154700107 | ||
| 0.254 | 0.003 | 0.261 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.261 0.003 CID_154700107 | CID_154700107 | |
| 0.253 | 0.006 | 0.253 | Aromatase inhibitor | |||
| 0.248 | 0.004 | 0.248 | Xanthine dehydrogenase inhibitor | 0.138 0.008 CID_154700107 | ||
| 0.312 | 0.069 | 0.312 | Sodium/bile acid cotransporter inhibitor | 0.243 0.136 CID_154700107 | ||
| 0.258 | 0.015 | 0.258 | Protein kinase (CK2) alpha inhibitor | |||
| 0.244 | 0.004 | 0.244 | Estrogen receptor beta agonist | 0.101 0.011 CID_154700107 | ||
| 0.293 | 0.055 | 0.293 | Dyrk kinase inhibitor | |||
| 0.245 | 0.007 | 0.245 | HIV-1 integrase (3'-Processing) inhibitor | 0.125 0.018 CID_154700107 | ||
| 0.241 | 0.004 | 0.241 | DNA-dependent protein kinase inhibitor | |||
| 0.253 | 0.016 | 0.253 | Protein-tyrosine phosphatase 1B inhibitor | 0.236 0.019 CID_154700107 | ||
| 0.256 | 0.022 | 0.397 | Alpha-N-acetylglucosaminidase inhibitor | 0.397 0.009 CID_154700107 | CID_154700107 | |
| 0.239 | 0.005 | 0.239 | Papain-like protease (SARS coronavirus) inhibitor | 0.119 0.083 CID_154700107 | ||
| 0.24 | 0.008 | 0.24 | Alcohol dehydrogenase inhibitor | 0.202 0.012 CID_154700107 | ||
| 0.254 | 0.024 | 0.254 | Phospholipase C inhibitor | 0.212 0.037 CID_154700107 | ||
| 0.231 | 0.004 | 0.231 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.259 | 0.033 | 0.259 | Mcl-1 antagonist | |||
| 0.24 | 0.016 | 0.397 | ATPase inhibitor | 0.397 0.004 CID_154700107 | CID_154700107 | |
| 0.229 | 0.005 | 0.229 | Histone deacetylase stimulant | 0.213 0.005 CID_154700107 | ||
| 0.229 | 0.005 | 0.229 | Histone deacetylase SIRT1 stimulant | 0.213 0.005 CID_154700107 | ||
| 0.238 | 0.015 | 0.256 | Mannose-6-phosphate isomerase inhibitor | 0.256 0.011 CID_154700107 | CID_154700107 | |
| 0.263 | 0.041 | 0.36 | DNA methyltransferase I inhibitor | 0.36 0.013 CID_154700107 | CID_154700107 | |
| 0.23 | 0.008 | 0.23 | Protein kinase C zeta inhibitor | |||
| 0.269 | 0.048 | 0.269 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.274 | 0.054 | 0.433 | DNA synthesis inhibitor | 0.433 0.018 CID_154700107 | CID_154700107 | |
| 0.225 | 0.006 | 0.225 | Keratolytic | |||
| 0.225 | 0.006 | 0.225 | Electron transport complex I inhibitor | 0.121 0.046 CID_154700107 | ||
| 0.222 | 0.005 | 0.222 | Cyclin B3 inhibitor | |||
| 0.278 | 0.062 | 0.514 | Tumour necrosis factor alpha release inhibitor | 0.514 0.013 CID_154700107 | CID_154700107 | |
| 0.225 | 0.009 | 0.331 | Photosensitizer | 0.331 0.004 CID_154700107 | CID_154700107 | |
| 0.271 | 0.056 | 0.271 | Gastrin inhibitor | 0.22 0.12 CID_154700107 | ||
| 0.217 | 0.005 | 0.217 | Alpha tubulin antagonist | |||
| 0.218 | 0.008 | 0.218 | HIV-1 integrase (Strand Transfer) inhibitor | 0.11 0.019 CID_154700107 | ||
| 0.24 | 0.031 | 0.24 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.266 | 0.058 | 0.266 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.211 | 0.005 | 0.228 | Heat shock protein 70 antagonist | 0.228 0.004 CID_154700107 | CID_154700107 | |
| 0.221 | 0.016 | 0.221 | Toll-Like receptor 2 antagonist | |||
| 0.245 | 0.04 | 0.245 | I kappa B kinase epsilon inhibitor | |||
| 0.22 | 0.015 | 0.22 | Protein kinase (CK2) inhibitor | |||
| 0.241 | 0.036 | 0.241 | Amyloid beta precursor protein antagonist | |||
| 0.224 | 0.021 | 0.224 | Death-associated protein kinase 2 inhibitor | |||
| 0.259 | 0.058 | 0.259 | Interleukin antagonist | |||
| 0.216 | 0.016 | 0.412 | UDP-glucose 4-epimerase inhibitor | 0.412 0.005 CID_154700107 | CID_154700107 | |
| 0.293 | 0.093 | 0.711 | Antithrombotic | 0.711 0.008 CID_154700107 | CID_154700107 | |
| 0.207 | 0.008 | 0.481 | DNA repair enzyme inhibitor | 0.481 0.003 CID_154700107 | CID_154700107 | |
| 0.239 | 0.041 | 0.239 | Insulin sensitizer | 0.231 0.046 CID_154700107 | ||
| 0.202 | 0.003 | 0.202 | GABA B receptor antagonist | |||
| 0.201 | 0.007 | 0.201 | CDC25A inhibitor | 0.088 0.036 CID_154700107 | ||
| 0.22 | 0.027 | 0.411 | Insulin secretagoues | 0.411 0.006 CID_154700107 | CID_154700107 | |
| 0.291 | 0.097 | 0.569 | Cholesterol antagonist | 0.569 0.023 CID_154700107 | CID_154700107 | |
| 0.203 | 0.01 | 0.203 | TRPA1 agonist | 0.134 0.044 CID_154700107 | ||
| 0.196 | 0.005 | 0.196 | Myeloperoxidase inhibitor | |||
| 0.213 | 0.022 | 0.213 | Arachidonic acid antagonist | 0.151 0.087 CID_154700107 | ||
| 0.203 | 0.014 | 0.203 | Potassium channel (Ca-activated) activator | |||
| 0.198 | 0.009 | 0.198 | Prolactin inhibitor | |||
| 0.19 | 0.004 | 0.19 | D-Ala-D-Ala ligase inhibitor | |||
| 0.225 | 0.04 | 0.225 | Tumour necrosis factor antagonist | |||
| 0.214 | 0.029 | 0.214 | Cyclooxygenase 1 inhibitor | 0.142 0.061 CID_154700107 | ||
| 0.213 | 0.028 | 0.387 | Hexokinase inhibitor | 0.387 0.005 CID_154700107 | CID_154700107 | |
| 0.219 | 0.034 | 0.219 | Cyclooxygenase inhibitor | 0.151 0.069 CID_154700107 | ||
| 0.187 | 0.005 | 0.187 | Estrogen receptor alpha agonist | |||
| 0.237 | 0.056 | 0.36 | DNA methylase inhibitor | 0.36 0.015 CID_154700107 | CID_154700107 | |
| 0.206 | 0.025 | 0.407 | Alkylator | 0.407 0.007 CID_154700107 | CID_154700107 | |
| 0.194 | 0.013 | 0.194 | Porphobilinogen synthase inhibitor | |||
| 0.184 | 0.004 | 0.184 | Fatty acid synthase inhibitor | 0.1 0.011 CID_154700107 | ||
| 0.188 | 0.012 | 0.188 | Urease inhibitor | |||
| 0.206 | 0.032 | 0.206 | Neurotensin receptor agonist | |||
| 0.194 | 0.021 | 0.52 | Cyclooxygenase 3 inhibitor | 0.52 0.003 CID_154700107 | CID_154700107 | |
| 0.183 | 0.01 | 0.183 | CYP2A6 inhibitor | |||
| 0.263 | 0.091 | 0.546 | Immunostimulant | 0.546 0.023 CID_154700107 | CID_154700107 | |
| 0.176 | 0.005 | 0.176 | CD45 antagonist | |||
| 0.198 | 0.027 | 0.198 | Cholesterol synthesis inhibitor | 0.147 0.046 CID_154700107 | ||
| 0.318 | 0.147 | 0.822 | Cyclophilin D inhibitor | 0.822 0.005 CID_154700107 | CID_154700107 | |
| 0.277 | 0.107 | 0.277 | Thyroid hormone antagonist | |||
| 0.184 | 0.015 | 0.184 | Androgen antagonist | |||
| 0.178 | 0.011 | 0.189 | Thioredoxin inhibitor | 0.189 0.009 CID_154700107 | CID_154700107 | |
| 0.176 | 0.009 | 0.176 | Glutamate decarboxylase inhibitor | |||
| 0.189 | 0.022 | 0.189 | GABA C receptor agonist | |||
| 0.227 | 0.061 | 0.227 | Anesthetic general | 0.212 0.068 CID_154700107 | ||
| 0.231 | 0.066 | 0.235 | Psychostimulant | 0.235 0.064 CID_154700107 | CID_154700107 | |
| 0.18 | 0.016 | 0.18 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.184 | 0.023 | 0.184 | Adenylate cyclase stimulant | 0.132 0.097 CID_154700107 | ||
| 0.182 | 0.027 | 0.182 | Antibacterial (Helicobacter pylori) | 0.112 0.094 CID_154700107 | ||
| 0.161 | 0.008 | 0.161 | Thioredoxin reductase inhibitor | 0.09 0.041 CID_154700107 | ||
| 0.168 | 0.015 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.163 0.02 CID_154700107 | ||
| 0.159 | 0.008 | 0.159 | Carbonic anhydrase VB inhibitor | |||
| 0.26 | 0.112 | 0.26 | Thyroid hormone beta antagonist | |||
| 0.207 | 0.059 | 0.207 | Histone acetyltransferase inhibitor | |||
| 0.159 | 0.013 | 0.159 | Carbonic anhydrase V inhibitor | |||
| 0.162 | 0.016 | 0.162 | Transcription factor STAT6 inhibitor | |||
| 0.165 | 0.019 | 0.165 | Sphingomyelinase inhibitor | 0.138 0.03 CID_154700107 | ||
| 0.15 | 0.005 | 0.15 | Aryl hydrocarbon receptor antagonist | |||
| 0.157 | 0.011 | 0.157 | Beta tubulin antagonist | |||
| 0.182 | 0.037 | 0.182 | Cyclooxygenase 2 inhibitor | 0.126 0.074 CID_154700107 | ||
| 0.164 | 0.02 | 0.502 | AMP-activated protein kinase stimulant | 0.502 0.003 CID_154700107 | CID_154700107 | |
| 0.262 | 0.119 | 0.262 | Vasodilator, peripheral | 0.232 0.142 CID_154700107 | ||
| 0.148 | 0.005 | 0.148 | Protease activated receptor antagonist | |||
| 0.172 | 0.031 | 0.172 | MAP kinase kinase 4 inhibitor | |||
| 0.323 | 0.182 | 0.323 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.151 | 0.011 | 0.151 | Ornithine decarboxylase inhibitor | 0.125 0.022 CID_154700107 | ||
| 0.142 | 0.003 | 0.142 | Dopamine D5 agonist | |||
| 0.156 | 0.018 | 0.299 | Triose-phosphate isomerase inhibitor | 0.299 0.005 CID_154700107 | CID_154700107 | |
| 0.178 | 0.042 | 0.376 | Cell wall synthesis inhibitor | 0.376 0.007 CID_154700107 | CID_154700107 | |
| 0.137 | 0.004 | 0.137 | Glutamate (mGluR7) antagonist | |||
| 0.145 | 0.012 | 0.145 | Carbonic anhydrase VA inhibitor | |||
| 0.299 | 0.166 | 0.299 | DNA polymerase beta inhibitor | |||
| 0.14 | 0.007 | 0.14 | Carbonic anhydrase VII inhibitor | 0.061 0.019 CID_154700107 | ||
| 0.198 | 0.065 | 0.198 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.137 | 0.005 | 0.137 | Topoisomerase II beta inhibitor | 0.107 0.008 CID_154700107 | ||
| 0.149 | 0.018 | 0.149 | Anabolic | |||
| 0.291 | 0.166 | 0.291 | DNA directed DNA polymerase inhibitor | |||
| 0.179 | 0.054 | 0.179 | Phospholipase A2 inhibitor | 0.147 0.077 CID_154700107 | ||
| 0.186 | 0.061 | 0.186 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.138 | 0.014 | 0.138 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.143 | 0.019 | 0.279 | NADH dehydrogenase inhibitor | 0.279 0.007 CID_154700107 | CID_154700107 | |
| 0.161 | 0.038 | 0.161 | Adenylate cyclase inhibitor | 0.102 0.082 CID_154700107 | ||
| 0.153 | 0.03 | 0.163 | Mucolytic | 0.163 0.026 CID_154700107 | CID_154700107 | |
| 0.131 | 0.012 | 0.131 | HIV-1 integrase inhibitor | 0.069 0.05 CID_154700107 | ||
| 0.176 | 0.058 | 0.176 | Catenin beta inhibitor | |||
| 0.128 | 0.009 | 0.128 | CDC25B inhibitor | |||
| 0.13 | 0.013 | 0.13 | Leukotriene antagonist | 0.123 0.015 CID_154700107 | ||
| 0.121 | 0.007 | 0.121 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.158 | 0.045 | 0.182 | DNA polymerase I inhibitor | 0.182 0.034 CID_154700107 | CID_154700107 | |
| 0.165 | 0.053 | 0.492 | Hemostatic | 0.492 0.004 CID_154700107 | CID_154700107 | |
| 0.151 | 0.039 | 0.175 | Beta amyloid protein antagonist | 0.175 0.026 CID_154700107 | CID_154700107 | |
| 0.13 | 0.018 | 0.13 | Interleukin 5 antagonist | 0.114 0.028 CID_154700107 | ||
| 0.119 | 0.007 | 0.119 | Heat shock protein 90 beta antagonist | |||
| 0.126 | 0.015 | 0.126 | Potassium channel large-conductance Ca-activated activator | |||
| 0.143 | 0.032 | 0.311 | Antineoplastic antibiotic | 0.311 0.009 CID_154700107 | CID_154700107 | |
| 0.133 | 0.024 | 0.133 | Aminoacyl-tRNA synthetase inhibitor | 0.098 0.047 CID_154700107 | ||
| 0.119 | 0.01 | 0.119 | Estrogen-related receptor beta agonist | |||
| 0.112 | 0.004 | 0.112 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.119 | 0.011 | 0.119 | Maillard reaction inhibitor | 0.079 0.025 CID_154700107 | ||
| 0.111 | 0.005 | 0.111 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.143 | 0.038 | 0.426 | Expectorant | 0.426 0.004 CID_154700107 | CID_154700107 | |
| 0.11 | 0.005 | 0.11 | Transcription factor RelA inhibitor | |||
| 0.11 | 0.007 | 0.11 | MAP kinase kinase 7 inhibitor | |||
| 0.141 | 0.04 | 0.141 | 5 Hydroxytryptamine 3A agonist | |||
| 0.121 | 0.022 | 0.121 | Glutathione S-transferase inhibitor | |||
| 0.121 | 0.024 | 0.179 | Phosphodiesterase 6D inhibitor | 0.179 0.005 CID_154700107 | CID_154700107 | |
| 0.109 | 0.014 | 0.109 | GABA receptor antagonist | |||
| 0.108 | 0.013 | 0.108 | Beta 3 adrenoreceptor antagonist | |||
| 0.109 | 0.014 | 0.165 | Neuraminidase (influenza) inhibitor | 0.165 0.006 CID_154700107 | CID_154700107 | |
| 0.114 | 0.02 | 0.114 | mTOR complex 2 inhibitor | |||
| 0.108 | 0.014 | 0.108 | Purinergic P2X1 antagonist | 0.061 0.042 CID_154700107 | ||
| 0.129 | 0.037 | 0.129 | Adenylate kinase inhibitor | 0.097 0.072 CID_154700107 | ||
| 0.112 | 0.021 | 0.112 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.117 | 0.026 | 0.215 | Phosphofructokinase-1 inhibitor | 0.215 0.01 CID_154700107 | CID_154700107 | |
| 0.163 | 0.072 | 0.271 | Interleukin 6 antagonist | 0.271 0.019 CID_154700107 | CID_154700107 | |
| 0.126 | 0.038 | 0.185 | Toll-Like receptor 4 antagonist | 0.185 0.009 CID_154700107 | CID_154700107 | |
| 0.148 | 0.06 | 0.148 | Neurotrophic factor | 0.129 0.081 CID_154700107 | ||
| 0.109 | 0.022 | 0.109 | Leukotriene synthesis inhibitor | |||
| 0.09 | 0.003 | 0.09 | Estrogen-related receptor beta antagonist | |||
| 0.117 | 0.032 | 0.138 | Interleukin 12 antagonist | 0.138 0.017 CID_154700107 | CID_154700107 | |
| 0.09 | 0.005 | 0.09 | Adenylate cyclase 1 inhibitor | |||
| 0.132 | 0.048 | 0.132 | Interleukin 8 antagonist | |||
| 0.108 | 0.023 | 0.108 | Lipase inhibitor | 0.077 0.047 CID_154700107 | ||
| 0.099 | 0.016 | 0.138 | Neuraminidase inhibitor | 0.138 0.007 CID_154700107 | CID_154700107 | |
| 0.119 | 0.036 | 0.119 | MAP kinase kinase 1 inhibitor | |||
| 0.24 | 0.157 | 0.527 | Immunosuppressant | 0.527 0.026 CID_154700107 | CID_154700107 | |
| 0.133 | 0.05 | 0.204 | DNA intercalator | 0.204 0.025 CID_154700107 | CID_154700107 | |
| 0.142 | 0.062 | 0.142 | Farnesoid X receptor antagonist | |||
| 0.089 | 0.01 | 0.089 | Potassium channel Kv1.3 blocker | |||
| 0.083 | 0.005 | 0.083 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.135 | 0.057 | 0.135 | Vanilloid 1 agonist | 0.126 0.073 CID_154700107 | ||
| 0.082 | 0.004 | 0.082 | ATP citrate lysase inhibitor | |||
| 0.19 | 0.112 | 0.412 | Peptidyltransferase inhibitor | 0.412 0.006 CID_154700107 | CID_154700107 | |
| 0.117 | 0.041 | 0.15 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.15 0.027 CID_154700107 | CID_154700107 | |
| 0.132 | 0.057 | 0.132 | Proteasome inhibitor | |||
| 0.087 | 0.012 | 0.087 | Cyclin B2 inhibitor | |||
| 0.09 | 0.015 | 0.09 | Cyclin B1 inhibitor | |||
| 0.1 | 0.025 | 0.1 | Dopamine D1 antagonist | |||
| 0.09 | 0.016 | 0.09 | Glutamate (mGluR6) antagonist | |||
| 0.151 | 0.077 | 0.319 | Diuretic | 0.319 0.019 CID_154700107 | CID_154700107 | |
| 0.194 | 0.119 | 0.194 | Calpain inhibitor | |||
| 0.1 | 0.027 | 0.1 | GABA aminotransferase inhibitor | 0.092 0.033 CID_154700107 | ||
| 0.08 | 0.008 | 0.08 | Leukotriene C antagonist | 0.053 0.05 CID_154700107 | ||
| 0.079 | 0.007 | 0.079 | Cholesterol esterase inhibitor | |||
| 0.09 | 0.02 | 0.09 | Protein kinase C eta inhibitor | 0.048 0.047 CID_154700107 | ||
| 0.098 | 0.028 | 0.098 | Dopamine agonist | |||
| 0.1 | 0.031 | 0.122 | Na+ K+ transporting ATPase inhibitor | 0.122 0.015 CID_154700107 | CID_154700107 | |
| 0.11 | 0.041 | 0.11 | NMDA receptor antagonist | |||
| 0.078 | 0.01 | 0.078 | Ryanodine receptor antagonist | |||
| 0.121 | 0.052 | 0.121 | Aminopeptidase B inhibitor | |||
| 0.071 | 0.004 | 0.071 | Protein kinase (CK2) beta inhibitor | |||
| 0.084 | 0.017 | 0.084 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.082 | 0.016 | 0.124 | Carbonic anhydrase XIV inhibitor | 0.124 0.006 CID_154700107 | CID_154700107 | |
| 0.193 | 0.127 | 0.324 | Interleukin agonist | 0.324 0.038 CID_154700107 | CID_154700107 | |
| 0.098 | 0.032 | 0.098 | Glutamate dehydrogenase inhibitor | 0.069 0.059 CID_154700107 | ||
| 0.07 | 0.005 | 0.07 | Dopamine autoreceptor agonist | |||
| 0.13 | 0.065 | 0.13 | MAP kinase kinase inhibitor | |||
| 0.072 | 0.009 | 0.072 | Purinergic P2X4 antagonist | |||
| 0.083 | 0.02 | 0.083 | GABA A receptor antagonist | |||
| 0.081 | 0.018 | 0.081 | Cyclin D1 inhibitor | |||
| 0.084 | 0.022 | 0.084 | Androgen agonist | |||
| 0.077 | 0.017 | 0.127 | Leukotriene B4 antagonist | 0.127 0.006 CID_154700107 | CID_154700107 | |
| 0.088 | 0.028 | 0.088 | GABA B receptor agonist | |||
| 0.076 | 0.017 | 0.076 | Cyclin B inhibitor | |||
| 0.073 | 0.014 | 0.073 | Dihydroorotate oxidase inhibitor | |||
| 0.119 | 0.061 | 0.154 | Microtubule formation inhibitor | 0.154 0.035 CID_154700107 | CID_154700107 | |
| 0.165 | 0.108 | 0.165 | Antimitotic | |||
| 0.122 | 0.068 | 0.122 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.063 | 0.009 | 0.107 | Arginase inhibitor | 0.107 0.004 CID_154700107 | CID_154700107 | |
| 0.063 | 0.01 | 0.079 | Neuraminidase (Influenza A) inhibitor | 0.079 0.005 CID_154700107 | CID_154700107 | |
| 0.078 | 0.026 | 0.149 | Carbonic anhydrase XII inhibitor | 0.149 0.013 CID_154700107 | CID_154700107 | |
| 0.089 | 0.038 | 0.089 | Cathepsin G inhibitor | |||
| 0.07 | 0.019 | 0.07 | Aconitate hydratase inhibitor | |||
| 0.078 | 0.028 | 0.078 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.111 | 0.061 | 0.111 | Ferrochelatase inhibitor | |||
| 0.101 | 0.054 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.071 | 0.024 | 0.071 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.07 | 0.024 | 0.07 | Sphingosine kinase inhibitor | |||
| 0.054 | 0.008 | 0.054 | Leukotriene C4 antagonist | |||
| 0.099 | 0.052 | 0.099 | Bile acid receptor antagonist | |||
| 0.062 | 0.017 | 0.085 | Glucose-6-phosphate isomerase inhibitor | 0.085 0.007 CID_154700107 | CID_154700107 | |
| 0.057 | 0.012 | 0.057 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.218 | 0.173 | 0.218 | Calpain 2 inhibitor | |||
| 0.07 | 0.026 | 0.072 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.072 0.024 CID_154700107 | CID_154700107 | |
| 0.087 | 0.043 | 0.116 | T cell inhibitor | 0.116 0.015 CID_154700107 | CID_154700107 | |
| 0.07 | 0.026 | 0.07 | Heme oxygenase stimulant | |||
| 0.133 | 0.09 | 0.133 | Pregnane X receptor agonist | |||
| 0.126 | 0.083 | 0.126 | Cytokine production inhibitor | |||
| 0.077 | 0.034 | 0.077 | Protein kinase C beta inhibitor | |||
| 0.059 | 0.017 | 0.059 | NMDA receptor subunit 3A antagonist | |||
| 0.05 | 0.008 | 0.05 | Vanilloid 3 antagonist | |||
| 0.074 | 0.033 | 0.074 | NMDA receptor glycine site agonist | |||
| 0.06 | 0.019 | 0.06 | Dopamine D5 antagonist | |||
| 0.087 | 0.047 | 0.087 | Caspase 7 inhibitor | |||
| 0.048 | 0.008 | 0.048 | Estrone sulfatase inhibitor | |||
| 0.052 | 0.012 | 0.052 | Sirtuin 2 inhibitor | |||
| 0.073 | 0.033 | 0.073 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.103 | 0.063 | 0.103 | Alpha 2c adrenoreceptor antagonist | |||
| 0.081 | 0.041 | 0.081 | Adenosine A3 receptor antagonist | |||
| 0.085 | 0.045 | 0.107 | Interferon agonist | 0.107 0.023 CID_154700107 | CID_154700107 | |
| 0.053 | 0.014 | 0.053 | DNA gyrase subunit A inhibitor | 0.039 0.038 CID_154700107 | ||
| 0.073 | 0.035 | 0.073 | Beta adrenoreceptor antagonist | |||
| 0.06 | 0.022 | 0.06 | CXC chemokine 1 receptor antagonist | |||
| 0.059 | 0.021 | 0.059 | Squalene epoxidase inhibitor | |||
| 0.068 | 0.031 | 0.068 | Argininosuccinate synthase inhibitor | |||
| 0.05 | 0.014 | 0.05 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.077 | 0.042 | 0.077 | Glycine receptor agonist | 0.07 0.054 CID_154700107 | ||
| 0.062 | 0.028 | 0.062 | NMDA 2A receptor antagonist | |||
| 0.084 | 0.051 | 0.13 | Glycine receptor antagonist | 0.13 0.014 CID_154700107 | CID_154700107 | |
| 0.044 | 0.011 | 0.044 | Catechol O-methyltransferase inhibitor | |||
| 0.073 | 0.041 | 0.073 | Sirtuin 1 inhibitor | |||
| 0.085 | 0.053 | 0.085 | Inducible nitric-oxide synthase inhibitor | |||
| 0.077 | 0.045 | 0.077 | Aminopeptidase I inhibitor | |||
| 0.109 | 0.077 | 0.109 | Caspase 3 inhibitor | |||
| 0.06 | 0.03 | 0.06 | Pregnane X receptor antagonist | |||
| 0.052 | 0.022 | 0.052 | Cathepsin L2 inhibitor | |||
| 0.053 | 0.023 | 0.053 | NMDA receptor subunit 3B antagonist | |||
| 0.087 | 0.058 | 0.087 | Calcium antagonist | |||
| 0.13 | 0.101 | 0.13 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.076 | 0.048 | 0.082 | Phosphodiesterase VI inhibitor | 0.082 0.038 CID_154700107 | CID_154700107 | |
| 0.045 | 0.016 | 0.045 | Glutamate (mGluR8) agonist | |||
| 0.101 | 0.074 | 0.101 | Alpha 2b adrenoreceptor antagonist | |||
| 0.048 | 0.021 | 0.048 | Liver X receptor alpha agonist | |||
| 0.033 | 0.007 | 0.033 | Glutamate (mGluR1a) agonist | |||
| 0.055 | 0.03 | 0.114 | Glucose-6-phosphate translocase inhibitor | 0.114 0.005 CID_154700107 | CID_154700107 | |
| 0.074 | 0.048 | 0.074 | MAP3K7 inhibitor | |||
| 0.051 | 0.026 | 0.064 | Cytokine production stimulant | 0.064 0.01 CID_154700107 | CID_154700107 | |
| 0.052 | 0.027 | 0.052 | Dopamine beta hydroxylase inhibitor | |||
| 0.181 | 0.157 | 0.181 | Neuropeptide Y2 antagonist | |||
| 0.037 | 0.013 | 0.037 | Glutamate (mGluR3) agonist | |||
| 0.033 | 0.01 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.033 | 0.01 | 0.033 | Thyroid hormone agonist | |||
| 0.103 | 0.081 | 0.103 | Acetylcholine release stimulant | 0.103 0.08 CID_154700107 | ||
| 0.054 | 0.032 | 0.054 | Sigma receptor antagonist | |||
| 0.091 | 0.07 | 0.091 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.071 | 0.05 | 0.071 | NMDA 2 receptor antagonist | |||
| 0.026 | 0.005 | 0.043 | Antibiotic Anthracycline-like | 0.043 0.002 CID_154700107 | CID_154700107 | |
| 0.081 | 0.06 | 0.081 | CC chemokine 5 receptor agonist | |||
| 0.062 | 0.041 | 0.062 | TRPA1 antagonist | |||
| 0.062 | 0.042 | 0.062 | NMDA 2C receptor antagonist | |||
| 0.088 | 0.068 | 0.093 | Glutamate release inhibitor | 0.093 0.056 CID_154700107 | CID_154700107 | |
| 0.028 | 0.008 | 0.028 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.046 | 0.026 | 0.046 | Glutamate (mGluR group III) antagonist | |||
| 0.039 | 0.02 | 0.039 | Retinoid X alpha receptor agonist | |||
| 0.036 | 0.017 | 0.036 | Protein kinase C beta I inhibitor | 0.033 0.025 CID_154700107 | ||
| 0.06 | 0.041 | 0.06 | Biliverdin reductase inhibitor | |||
| 0.044 | 0.026 | 0.044 | Heme oxygenase inhibitor | |||
| 0.03 | 0.013 | 0.119 | Sodium/glucose cotransporter 2 inhibitor | 0.119 0.002 CID_154700107 | CID_154700107 | |
| 0.041 | 0.024 | 0.041 | Retinoic acid alpha receptor agonist | |||
| 0.11 | 0.093 | 0.11 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.063 | 0.046 | 0.08 | Interferon inducer | 0.08 0.024 CID_154700107 | CID_154700107 | |
| 0.061 | 0.046 | 0.061 | NMDA receptor agonist | |||
| 0.053 | 0.038 | 0.179 | Heparanase inhibitor | 0.179 0.002 CID_154700107 | CID_154700107 | |
| 0.222 | 0.207 | 0.222 | Transcription factor inhibitor | |||
| 0.026 | 0.012 | 0.028 | Leukotriene B4 receptor 2 antagonist | 0.028 0.009 CID_154700107 | CID_154700107 | |
| 0.034 | 0.021 | 0.034 | Estrogen-related receptor alpha antagonist | |||
| 0.039 | 0.025 | 0.039 | Retinoid X receptor antagonist | |||
| 0.027 | 0.014 | 0.109 | Sodium/glucose cotransporter inhibitor | 0.109 0.002 CID_154700107 | CID_154700107 | |
| 0.059 | 0.046 | 0.06 | Carbonic anhydrase inhibitor | 0.06 0.046 CID_154700107 | CID_154700107 | |
| 0.037 | 0.024 | 0.037 | ATM kinase inhibitor | |||
| 0.027 | 0.014 | 0.045 | Vanilloid 2 agonist | 0.045 0.003 CID_154700107 | CID_154700107 | |
| 0.113 | 0.1 | 0.113 | Interleukin 1 antagonist | |||
| 0.057 | 0.045 | 0.057 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.072 | 0.06 | 0.072 | Vanilloid 4 agonist | |||
| 0.017 | 0.006 | 0.017 | Antibiotic Tetracycline-like | |||
| 0.079 | 0.068 | 0.079 | Histamine N-methyltransferase inhibitor | |||
| 0.051 | 0.041 | 0.051 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.049 | 0.038 | 0.049 | Beta 2 adrenoreceptor antagonist | |||
| 0.022 | 0.012 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.131 | 0.121 | 0.131 | Antipruritic | |||
| 0.042 | 0.032 | 0.042 | Dopamine D2 agonist | |||
| 0.088 | 0.078 | 0.088 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.054 | 0.044 | 0.054 | Adenosine A1 receptor antagonist | |||
| 0.116 | 0.107 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.034 | 0.025 | 0.034 | Progesterone antagonist | |||
| 0.119 | 0.111 | 0.366 | Thrombolytic | 0.366 0.015 CID_154700107 | CID_154700107 | |
| 0.023 | 0.015 | 0.023 | Prostaglandin F2 alpha agonist | |||
| 0.035 | 0.028 | 0.035 | Glutamate (mGluR3) antagonist | |||
| 0.126 | 0.119 | 0.126 | MAP kinase 3 inhibitor | |||
| 0.024 | 0.018 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.063 | 0.056 | 0.063 | CDK1/cyclin B1 inhibitor | |||
| 0.025 | 0.019 | 0.025 | Leukotriene D4 antagonist | |||
| 0.065 | 0.06 | 0.065 | Phosphodiesterase 4D inhibitor | |||
| 0.017 | 0.012 | 0.017 | Nicotinic acid receptor 1 antagonist | |||
| 0.046 | 0.041 | 0.046 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.022 | 0.017 | 0.034 | Dopamine D1 agonist | 0.034 0.007 CID_154700107 | CID_154700107 | |
| 0.042 | 0.038 | 0.042 | Adenosine deaminase inhibitor | |||
| 0.093 | 0.089 | 0.093 | Protein kinase C gamma inhibitor | |||
| 0.038 | 0.034 | 0.038 | Oxytocin agonist | |||
| 0.039 | 0.035 | 0.046 | Guanylate cyclase inhibitor | 0.046 0.026 CID_154700107 | CID_154700107 | |
| 0.032 | 0.028 | 0.032 | Retinoid X receptor agonist | |||
| 0.025 | 0.023 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.047 | 0.045 | 0.072 | Carbonic anhydrase IX inhibitor | 0.072 0.031 CID_154700107 | CID_154700107 | |
| 0.03 | 0.028 | 0.03 | Fumarate hydratase inhibitor | |||
| 0.016 | 0.014 | 0.024 | Telomerase stimulant | 0.024 0.005 CID_154700107 | CID_154700107 | |
| 0.044 | 0.042 | 0.044 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.022 | 0.02 | 0.079 | Protein 30S ribosomal subunit inhibitor | 0.079 0.004 CID_154700107 | CID_154700107 | |
| 0.017 | 0.016 | 0.017 | Estrogen-related receptor gamma agonist | |||
| 0.037 | 0.036 | 0.037 | CF transmembrane conductance regulator antagonist | |||
| 0.043 | 0.042 | 0.043 | Aldosterone antagonist | |||
| 0.024 | 0.023 | 0.024 | Leukotriene B4 receptor 1 antagonist | 0.024 0.023 CID_154700107 | ||
| 0.047 | 0.05 | 0.093 | Alpha-mannosidase inhibitor | 0.093 0.008 CID_154700107 | CID_154700107 | |
| 0.119 | 0.124 | 0.156 | CC chemokine 6 receptor antagonist | 0.156 0.015 CID_154700107 | CID_154700107 | |
| 0.007 | 0.021 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.007 CID_154700107 | CID_154700107 | |
| 0.035 | 0.052 | 0.09 | Mannosidase inhibitor | 0.09 0.007 CID_154700107 | CID_154700107 | |
| 0.027 | 0.05 | 0.087 | Antibiotic Aminoglycoside-like | 0.087 0.004 CID_154700107 | CID_154700107 | |
| 0.049 | 0.074 | 0.069 | Lipocortins synthesis agonist | 0.069 0.022 CID_154700107 | CID_154700107 | |
| 0.135 | 0.162 | 0.373 | Platelet antagonist | 0.373 0.033 CID_154700107 | CID_154700107 | |
| 0.047 | 0.075 | 0.084 | Nitric oxide donor | 0.084 0.019 CID_154700107 | CID_154700107 | |
| 0.186 | 0.215 | 0.433 | Interleukin 2 agonist | 0.433 0.019 CID_154700107 | CID_154700107 | |
| 0.007 | 0.044 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 CID_154700107 | CID_154700107 | |
| 0.045 | 0.084 | 0.072 | Adenine nucleotide translocase inhibitor | 0.072 0.014 CID_154700107 | CID_154700107 | |
| 0.039 | 0.088 | 0.054 | Factor III inhibitor | 0.054 0.025 CID_154700107 | CID_154700107 | |
| 0.01 | 0.067 | 0.019 | Corticosteroid-like | 0.019 0.018 CID_154700107 | CID_154700107 | |
| 0.015 | 0.085 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 CID_154700107 | CID_154700107 | |
| 0.02 | 0.093 | 0.07 | Phosphorylase inhibitor | 0.07 0.02 CID_154700107 | CID_154700107 | |
| 0.06 | 0.14 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.128 0.015 CID_154700107 | CID_154700107 | |
| 0.036 | 0.125 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.052 CID_154700107 | CID_154700107 | |
| 0.025 | 0.119 | 0.05 | Microtubule stabilization | 0.05 0.028 CID_154700107 | CID_154700107 | |
| 0.002 | 0.107 | 0.013 | Antibiotic Macrolide-like | 0.013 0.01 CID_154700107 | CID_154700107 | |
| 0.101 | 0.207 | 0.317 | Hypolipemic | 0.317 0.044 CID_154700107 | CID_154700107 | |
| 0.049 | 0.164 | 0.103 | Falcipain 2 inhibitor | 0.103 0.05 CID_154700107 | CID_154700107 | |
| 0.021 | 0.137 | 0.117 | Protein 50S ribosomal subunit inhibitor | 0.117 0.01 CID_154700107 | CID_154700107 | |
| 0.05 | 0.168 | 0.105 | Falcipain inhibitor | 0.105 0.052 CID_154700107 | CID_154700107 | |
| 0.023 | 0.15 | 0.388 | Selectin antagonist | 0.388 0.003 CID_154700107 | CID_154700107 | |
| 0.048 | 0.253 | 0.144 | Transcription factor NF kappa B stimulant | 0.144 0.017 CID_154700107 | CID_154700107 | |
| 0.106 | 0.32 | 0.283 | Angiogenesis inhibitor | 0.283 0.102 CID_154700107 | CID_154700107 | |
| 0.021 | 0.259 | 0.063 | DNA gyrase inhibitor | 0.063 0.045 CID_154700107 | CID_154700107 | |
| 0.004 | 0.269 | 0.029 | Squalene synthetase inhibitor | 0.029 0.025 CID_154700107 | CID_154700107 | |
| 0.011 | 0.473 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.01 CID_154700107 | CID_154700107 | |
| 0.028 | 0.504 | 0.25 | Cell adhesion inhibitor | 0.25 0.015 CID_154700107 | CID_154700107 | |
| 0.012 | 0.572 | 0.116 | Cell adhesion molecule inhibitor | 0.116 0.025 CID_154700107 | CID_154700107 | |
| 0.046 | 0.608 | 0.421 | Immunomodulator | 0.421 0.038 CID_154700107 | CID_154700107 | |
| 0.015 | 0.598 | 0.083 | Factor IXa inhibitor | 0.083 0.015 CID_154700107 | CID_154700107 | |
| 0.015 | 0.609 | 0.223 | Anticoagulant | 0.223 0.046 CID_154700107 | CID_154700107 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |